FTSE All-Share

FTSE All-Share handeln
5.735,46 PKT +15,93 PKT +0,28 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
05.11.20 AstraZeneca Hold Jefferies & Company Inc.
05.11.20 AstraZeneca Sell Goldman Sachs Group Inc.
04.11.20 HSBC buy Goldman Sachs Group Inc.
04.11.20 Barclays Neutral Goldman Sachs Group Inc.
04.11.20 BAT Outperform Credit Suisse Group
03.11.20 BAT buy Goldman Sachs Group Inc.
03.11.20 BP Outperform Bernstein Research
03.11.20 BP Equal-Weight Morgan Stanley
03.11.20 Shell (ex Royal Dutch Shell) overweight Morgan Stanley
03.11.20 National Grid overweight JP Morgan Chase & Co.
03.11.20 Prudential overweight Barclays Capital
02.11.20 AstraZeneca overweight JP Morgan Chase & Co.
30.10.20 Shell (ex Royal Dutch Shell) Outperform Credit Suisse Group
30.10.20 Shell (ex Royal Dutch Shell) Outperform RBC Capital Markets
30.10.20 GSK Underweight Barclays Capital
30.10.20 Shell (ex Royal Dutch Shell) Equal weight Barclays Capital
30.10.20 GSK buy Goldman Sachs Group Inc.
30.10.20 Lloyds Banking Group Outperform RBC Capital Markets
29.10.20 Lloyds Banking Group Sell Goldman Sachs Group Inc.
29.10.20 Lloyds Banking Group Neutral JP Morgan Chase & Co.
29.10.20 Shell (ex Royal Dutch Shell) Outperform RBC Capital Markets
29.10.20 GSK Neutral Credit Suisse Group
29.10.20 Shell (ex Royal Dutch Shell) buy Goldman Sachs Group Inc.
29.10.20 Shell (ex Royal Dutch Shell) buy UBS AG
29.10.20 Shell (ex Royal Dutch Shell) Neutral JP Morgan Chase & Co.
28.10.20 BP buy Kepler Cheuvreux
28.10.20 GSK buy Goldman Sachs Group Inc.
28.10.20 GSK buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
28.10.20 GSK buy Jefferies & Company Inc.
28.10.20 GSK Neutral JP Morgan Chase & Co.
28.10.20 BP Underperform RBC Capital Markets
28.10.20 HSBC Underperform Credit Suisse Group
28.10.20 BP buy UBS AG
28.10.20 HSBC Neutral UBS AG
28.10.20 BP Outperform Credit Suisse Group
28.10.20 HSBC Underweight Barclays Capital
27.10.20 Unilever buy Jefferies & Company Inc.
27.10.20 BP Outperform Bernstein Research
27.10.20 Unilever buy Jefferies & Company Inc.
27.10.20 BP overweight JP Morgan Chase & Co.